TG Therapeutics Inc (TGTX)

Finanzdaten der TG Therapeutics Inc-Aktie (TGTX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	73.48% 43.97	165.81	16.07	7.803	0.08
Cost Of Revenue	123.82% 7.854	3.509	-	-	-
Gross Profit	77.75% 36.12	162.31	-	-	-
Operating Expenses	2.27% 48.60	47.52	60.75	44.80	52.14
Interest Income/Expense	34.53% 2.431	3.713	3.627	2.844	2.862
Benefits Costs and Expenses	25.47% 64.03	51.03	63.68	47.03	53.07
Costs And Expenses	10.63% 56.46	51.03	63.68	47.03	53.07
Operating Income/Loss	110.88% -12.48	114.78	-44.67	-36.99	-52.06
Nonoperating Income/Loss	80.44% -1.541	-0.854	-2.936	-2.24	-0.932
Income/Loss From Continuing Operations Before Tax	117.47% -20.06	114.78	-47.61	-39.23	-52.99
Income/Loss From Continuing Operations After Tax	112.65% -14.42	113.93	-47.61	-39.23	-52.99
Net Income/Loss	112.65% -14.42	113.93	-47.61	-39.23	-52.99
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.73% 0.3833	142.87	141.50	140.31	0.5721
Diluted Average Shares	98.36% 2.5556	155.87	141.50	140.31	0.5721
Basic Earnings Per Share	112.50% -0.10	0.80	-0.34	-0.28	-0.38
Diluted Earnings Per Share	113.70% -0.10	0.73	-0.34	-0.28	-0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-